Literature DB >> 22488565

Intra-abdominal pressure, LUTS, and tadalafil. Re: Andersson K-E, et al. tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol urodyn 2011;30:292-301.

Paul G Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22488565     DOI： 10.1002/nau.21209

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN： 0733-2467            Impact factor:   2.696


× No keyword cloud information.
  3 in total

Review 1.  BPH in 2012: novel agents in treatment of BPH.

Authors:  Bilal Chughtai; Alexis Te
Journal:  Nat Rev Urol       Date:  2013-01-08       Impact factor: 14.432

2.  Efficacy and safety of PDE5-Is and α-1 blockers for treating lower ureteric stones or LUTS: a meta-analysis of RCTs.

Authors:  Xifeng Sun; Wei Guan; Haoran Liu; Kun Tang; Libin Yan; Yangjun Zhang; Jin Zeng; Zhiqiang Chen; Hua Xu; Zhangqun Ye
Journal:  BMC Urol       Date:  2018-05-03       Impact factor: 2.264

Review 3.  Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis.

Authors:  Chengquan Ma; Jianzhong Zhang; Zhonglin Cai; Jian Xiong; Hongjun Li
Journal:  Biomed Res Int       Date:  2020-03-26       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.